| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |